The West Virginia Oncology Society (WVOS) 2023 Fall Conference is a unique opportunity to innovate with peers and engage in discussions that will help shape the future of cancer care across the state. This event will delve into two crucial themes: "The Role of Liquid Biopsies in Oncology: Applications, Hurdles, and Prospects" and "Boosting Rural Trials: Involving Communities and Fostering Collaboration." Additionally, there will be a networking reception, as well as a chance to connect with the pharmaceutical industry to gain insights into the latest developments in cancer treatment.
PROVIDER REGISTRATION DOWNLOAD AGENDA
Provider Registration - inclusive of licensed physicians and allied health professionals including but not limited to registered nurses, nurse practitioners, clinical nurse specialists, pharmacists, physician assistants, administrators, social workers, and office managers in an oncology practice or university; Fellows; Retirees. Provider registrants must not be employed by an Industry company (see below).
If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company:
Industry Registration – open only to confirmed exhibitors. A registration link will be sent via email approximately 7-8 weeks prior to the event. Any Industry attendees that register as a Provider will be voided. Please email firstname.lastname@example.org with any questions.
For assistance with provider registration, please email Amanda Impellizzeri, Leadership Relations Manager, at email@example.com.
For assistance with industry registration, please email our Corporate Development department.
The Erickson Alumni Center
1 Alumni Drive
Morgantown, WV 26506
This conference will not be awarding continuing education credits for physicians and nurses. If you have any questions or require assistance with your conference registration, please don't hesitate to contact us.
Friday, October 6, 2023
12:15 - 1:15 PM Central Time
This live, virtual symposium will bring together a nationally recognized expert in the management of breast cancer and a local thought leader to present key data that guide clinical decision-making in the context of real-world clinical scenarios. Participants will have the opportunity to reflect on how experts manage HER2+ and HER2-low breast cancer regarding initiating and sequencing therapy, as well as best practices in managing adverse events. This interactive program will allow clinicians to collectively consider the ramifications for care of new approaches to the treatment and clinical management of HER2+ and HER2-low metastatic breast cancer.
This educational program is directed toward community-based medical oncologists, surgical oncologists, nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment of breast cancer.
12:15 - 12:20PM CT: Welcome and Introductions
12:20 - 12:45PM CT: HER2+ Metastatic Breast Cancer – Earlier to Later Lines of Metastatic Breast Cancer
12:45 - 1:10PM CT: Are You Feeling HER2-Low? Navigating Novel Advances and New Questions
1:10 - 1:15PM CT: Q&A and Conclusions
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities.
If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org.
SUBSCRIBE TO RECEIVE EMAIL UPDATES